DeSimone Daniel C, Chahal Anwar A, DeSimone Christopher V, Asirvatham Samuel J, Friedman Paul A, Baddour Larry M, Sohail M Rizwan
Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA.
Pacing Clin Electrophysiol. 2017 Nov;40(11):1260-1268. doi: 10.1111/pace.13183. Epub 2017 Sep 20.
Cardiovascular implantable electronic devices (CIEDs) can be life-saving. However, complications from CIED infection can be life-threatening, often requiring device removal. Despite publication of CIED infection management guidelines, there remains marked variation in clinical practice.
To better understand and quantify these differences, we conducted a multinational survey of practitioners of CIED management.
An electronic survey was sent to Heart Rhythm Society members, spanning 70 countries across six continents. All responses were collected anonymously.
227 out of 3,600 (6.3%) responded to the survey. The majority of surveys were completed by practitioners from the United States (168; 68.3%) and 53.8% of these practiced in academic medical centers. The large majority (92.7%) of sites had protocols to ensure appropriate timing of prophylactic antibiotics. Superficial (incisional) site infections were treated with antibiotics alone 52.5% of the time (consistent with guidelines); in contrast, deep pocket infections were treated with antibiotics (with device removal) in accordance to guidelines only 37.4% of the time. Almost all providers (98.7%) were inclined to perform complete hardware removal in cases of CIED-related endocarditis. In contrast, 82.2% of survey participants suggested complete CIED system removal in patients with an occult Gram-positive bacteremia, 65.5% with occult Gram-negative bacteremia, and 59.3% with prolonged bacteremia due to a source other than CIED.
These data suggest wide variability in clinical practice in managing CIED infection with significant deviations from published guidelines. There is critical need to increase awareness and develop institutional protocols to ensure adherence with evidence-based guidelines to optimize outcomes.
心血管植入式电子设备(CIEDs)可挽救生命。然而,CIED感染引发的并发症可能危及生命,常常需要移除设备。尽管已发布CIED感染管理指南,但临床实践中仍存在显著差异。
为了更好地理解并量化这些差异,我们对CIED管理从业者进行了一项跨国调查。
向心律协会成员发送了电子调查问卷,覆盖六大洲的70个国家。所有回复均匿名收集。
3600名受访者中有227人(6.3%)回复了调查。大多数调查问卷由来自美国的从业者完成(168人;68.3%),其中53.8%在学术医疗中心工作。绝大多数(92.7%)机构有方案确保预防性抗生素的使用时机恰当。浅表(切口)部位感染有52.5%的时间仅用抗生素治疗(符合指南);相比之下,深部囊袋感染按照指南仅37.4%的时间使用抗生素(同时移除设备)。几乎所有医疗服务提供者(98.7%)倾向于在CIED相关心内膜炎病例中完全移除硬件。相比之下,82.2%的调查参与者建议在隐匿性革兰氏阳性菌血症患者中完全移除CIED系统,65.5%在隐匿性革兰氏阴性菌血症患者中建议如此,59.3%在因CIED以外的其他来源导致的持续性菌血症患者中建议如此。
这些数据表明在CIED感染管理的临床实践中存在很大差异,与已发布的指南有显著偏差。迫切需要提高认识并制定机构方案,以确保遵循循证指南来优化治疗结果。